Diet & Nutrition News and Research

Latest Diet & Nutrition News and Research

Bayer's SAFYRAL oral contraceptive receives FDA approval

Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.

17 Dec 2010

Study: Natural high hemoglobin levels safe for kidney disease patients on dialysis

Naturally occurring high hemoglobin levels are safe for kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

17 Dec 2010

Researchers discover allium vegetable consumption may lower hip osteoarthritis

Researchers at King's College London and the University of East Anglia have discovered that women who consume a diet high in allium vegetables, such as garlic, onions and leeks, have lower levels of hip osteoarthritis

16 Dec 2010

Quarter of all British school children obese: Report

A quarter of all British school children are obese and by the final year of primary school, the proportion rises to a third. Experts believe that this is not even the actual figure because many children opt out of being weighed. Urban children were much more likely to be overweight than those living in more rural areas.

16 Dec 2010

Genome is one more factor to blame for unwanted pounds

In addition to fast food, desk jobs, and inertia, there is one more thing to blame for unwanted pounds-our genome, which has apparently not caught up with the fact that we no longer live in the Stone Age.

16 Dec 2010

Omega-3 EPA or combination of EPA and DHA provide clear antidepressant benefits

Researchers at the University of Illinois at Chicago completed a review of previously published research on antidepressant benefits of Omega-3 essential fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The review comprised a meta-analysis of 15 randomized, double-blind, placebo-controlled studies in patients with depression and results were presented at the recent annual meeting of the American College of Neuropsychopharmacology.

16 Dec 2010

Amarin completes patient randomization in AMR101 Phase 3 trial in patients with high triglyceride levels

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported the completion of patient randomization for its ANCHOR trial, a pivotal Phase 3 trial of AMR101. The Company indicated that it anticipates reporting top-line results from this trial in Q2 2011.

16 Dec 2010

Determinants of health have stronger impact on Canadians' health than healthy lifestyle

A report released today by the Health Council of Canada declares that unless governments change their approach to addressing the needs of poorer and socially disadvantaged Canadians, we are destined to continue to spend large amount of dollars on our health care system. Governments must expand their approach to health promotion in order to tackle the major societal factors that lead to poor health and to take pressure off health care budgets.

16 Dec 2010

New study says celiac disease patients should go on gluten-free diet

Findings from a new study of 141 adults add to an ongoing medical debate over which patients with symptoms of celiac disease should go on a gluten-free diet. Published in ACS' Journal of Proteome Research, the study concludes that people currently diagnosed as "potential" celiac disease patients and not advised to follow a gluten-free diet may not be "potential" patients at all. Rather, the scientists found that these patients have the same distinctive metabolic fingerprint as patients with full-blown disease who do benefit from gluten-free diets.

16 Dec 2010

BPA exposure reduces quality of womens' eggs retrieved for IVF

A small-scale University of California, San Francisco-led study has identified the first evidence in humans that exposure to bisphenol A (BPA) may compromise the quality of a woman's eggs retrieved for in vitro fertilization (IVF). As blood levels of BPA in the women studied doubled, the percentage of eggs that fertilized normally declined by 50 percent, according to the research team.

16 Dec 2010

Almonds can help treat, prevent type 2 diabetes and cardiovascular disease

With nearly 16 million Americans living today with pre-diabetes, a condition that is the precursor to type 2 diabetes, and half of all Americans expected to have some form of diabetes by the year 2020, healthy eating is more important than ever. But here is some good news: a recent scientific study shows that incorporating almonds into your diet can help treat and possibly prevent type 2 diabetes, as well as cardiovascular disease.

15 Dec 2010

Atrium acquires Belgium-based Minami Nutrition

Atrium Innovations Inc., a recognized leading developer, manufacturer and marketer of professionally endorsed, science-based dietary supplements for the health and nutrition industry, today announced the purchase of Belgium-based Minami Nutrition, a niche brand of superior quality scientifically proven Omega-3 products primarily sold in several European countries.

15 Dec 2010

DSM licenses c-LEcta's alcohol dehydrogenases for enzyme screening programs

DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, today announces a license agreement with c-LEcta GmbH for proprietary screening technology.

15 Dec 2010

Children in Sweden are exposed to a huge number of unhealthy TV advertisements

Children in Sweden are exposed to a huge number of TV advertisements. Food adverts - primarily for fast food and sweets - dominate the advertisements shown during children's viewing times. Research from the University of Gothenburg, Sweden, shows that Sweden is no different from other countries when it comes to the number of adverts that children are exposed to.

15 Dec 2010

Research reveals mother's eating habits have huge impact on children's nutrition

As health professionals search for ways to combat the rise in obesity and promote healthy eating, new research reveals a mother's own eating habits - and whether she views her child as a 'picky eater' - has a huge impact on whether her child consumes enough fruits and vegetables.

15 Dec 2010

Davita launches online tool for dialysis patients

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease and end stage renal disease, today announced the launch of MyDaVita, an online tool intended to help patients connect with one another for friendship, support and educational information.

15 Dec 2010

IOM reconfirms the importance of calcium and vitamin D intake

Recently, the Institute of Medicine examined and reconfirmed the importance of calcium and vitamin D throughout life in a report titled "Dietary Reference Intakes for Calcium and Vitamin D."

15 Dec 2010

Poverty and obesity links

According to U.S. government researchers in a new report, women who are poor are much more likely to be obese but men are not. They revealed this Tuesday that where income does not greatly affect whether a man is obese, education affects both sexes. The team at the National Center for Health Statistics writes, “Among men, obesity prevalence is generally similar at all income levels, with a tendency to be slightly higher at higher income levels.”

14 Dec 2010

SunOpta subsidiary closes acquisition of Edner

SunOpta Inc. today announced that its indirect wholly-owned subsidiary SunOpta Fruit Group Inc. has completed the previously announced acquisition of the assets and business of Edner of Nevada, Inc..

14 Dec 2010

VIVUS submits briefing document to FDA in effort to secure regulatory approval for QNEXA

VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.

14 Dec 2010